Tower Research Capital LLC (Trc) Ikena Oncology, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Ikena Oncology, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,633 shares of IKNA stock, worth $4,977. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,633
Previous 1,875
93.76%
Holding current value
$4,977
Previous $3,000
66.67%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding IKNA
# of Institutions
55Shares Held
31.9MCall Options Held
0Put Options Held
0-
Atlas Venture Life Science Advisors, LLC5.02MShares$6.87 Million1.36% of portfolio
-
Blue Owl Capital Holdings LP New York, NY4.09MShares$5.6 Million2.87% of portfolio
-
Bvf Inc San Francisco, CA4.01MShares$5.49 Million0.25% of portfolio
-
Bml Capital Management, LLC Zionsville, IN3.59MShares$4.91 Million3.65% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.54MShares$4.85 Million0.16% of portfolio
About Ikena Oncology, Inc.
- Ticker IKNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,257,500
- Market Cap $49.7M
- Description
- Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. I...